You have 9 free searches left this month | for more free features.

Condition

Breast Cancer (1)

Glioblastoma (1)

Malignant Glioma (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 3 (1)

Sponsor

AstraZeneca (1)

Duke University (1)

Collaborator

Intervention

arimidex (anastrazole) (1)

evolocumab (1)

nolvadex (tamoxifen) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

PEskE

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting

Malignant Glioma
Glioblastoma

Evolocumab

Durham, North Carolina

Duke University Medical Center

Oct 13, 2022

Breast Cancer Trial in Worldwide (ARIMIDEX (anastrazole), NOLVADEX (tamoxifen))

Completed

Breast Cancer

ARIMIDEX (anastrazole)
NOLVADEX (tamoxifen)

Santa Rosa, California
+78 more

Feb 2, 2010